Elnas, Rosemary .

HRN: 07-66-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2023
CEFUROXIME 1.5GM (VIAL)
09/23/2023
09/23/2023
IV
1.5g
PTOR
AUB
Waiting Final Action 
09/27/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/27/2023
09/27/2023
IV
4.5
Now
AUB
Waiting Final Action 
09/27/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/27/2023
09/30/2023
IV
2.25
Q6
AUB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: